214 related articles for article (PubMed ID: 28314987)
1. Cooperative inhibitory effects of uremic toxins and other serum components on OATP1B1-mediated transport of SN-38.
Katsube Y; Tsujimoto M; Koide H; Ochiai M; Hojyo A; Ogawa K; Kambara K; Torii N; Shima D; Furukubo T; Izumi S; Yamakawa T; Minegaki T; Nishiguchi K
Cancer Chemother Pharmacol; 2017 Apr; 79(4):783-789. PubMed ID: 28314987
[TBL] [Abstract][Full Text] [Related]
2. Effects of Uremic Serum Residue on OATP1B1- and OATP1B3-Mediated Pravastatin Uptake in OATP-Expressing HEK293 Cells and Human Hepatocytes.
Uchiyama H; Tsujimoto M; Kimura A; Yuki E; Saiki T; Yoshida T; Furukubo T; Izumi S; Yamakawa T; Tachiki H; Minegaki T; Nishiguchi K
Ther Apher Dial; 2019 Apr; 23(2):126-132. PubMed ID: 30318712
[TBL] [Abstract][Full Text] [Related]
3. Organic anion transporting polypeptides 1B1 and 1B3 play an important role in uremic toxin handling and drug-uremic toxin interactions in the liver.
Sato T; Yamaguchi H; Kogawa T; Abe T; Mano N
J Pharm Pharm Sci; 2014; 17(4):475-84. PubMed ID: 25579430
[TBL] [Abstract][Full Text] [Related]
4. Direct inhibition and down-regulation by uremic plasma components of hepatic uptake transporter for SN-38, an active metabolite of irinotecan, in humans.
Fujita K; Sugiura T; Okumura H; Umeda S; Nakamichi N; Watanabe Y; Suzuki H; Sunakawa Y; Shimada K; Kawara K; Sasaki Y; Kato Y
Pharm Res; 2014 Jan; 31(1):204-15. PubMed ID: 23921491
[TBL] [Abstract][Full Text] [Related]
5. Role of organic anion transporter OATP1B1 (OATP-C) in hepatic uptake of irinotecan and its active metabolite, 7-ethyl-10-hydroxycamptothecin: in vitro evidence and effect of single nucleotide polymorphisms.
Nozawa T; Minami H; Sugiura S; Tsuji A; Tamai I
Drug Metab Dispos; 2005 Mar; 33(3):434-9. PubMed ID: 15608127
[TBL] [Abstract][Full Text] [Related]
6. Influence of serum in hemodialysis patients on the expression of intestinal and hepatic transporters for the excretion of pravastatin.
Tsujimoto M; Hatozaki D; Shima D; Yokota H; Furukubo T; Izumi S; Yamakawa T; Minegaki T; Nishiguchi K
Ther Apher Dial; 2012 Dec; 16(6):580-7. PubMed ID: 23190519
[TBL] [Abstract][Full Text] [Related]
7. Major role of organic anion transporter 3 in the transport of indoxyl sulfate in the kidney.
Deguchi T; Ohtsuki S; Otagiri M; Takanaga H; Asaba H; Mori S; Terasaki T
Kidney Int; 2002 May; 61(5):1760-8. PubMed ID: 11967025
[TBL] [Abstract][Full Text] [Related]
8. Acceleration of carboxylesterase-mediated activation of irinotecan to SN-38 by serum from patients with end-stage kidney disease.
Koide H; Tsujimoto M; Katsube Y; Ochiai M; Hojo A; Furukubo T; Izumi S; Yamakawa T; Shima D; Minegaki T; Nishiguchi K
Cancer Chemother Pharmacol; 2018 Jun; 81(6):1121-1128. PubMed ID: 29693202
[TBL] [Abstract][Full Text] [Related]
9. Investigation of Fluorescein Derivatives as Substrates of Organic Anion Transporting Polypeptide (OATP) 1B1 To Develop Sensitive Fluorescence-Based OATP1B1 Inhibition Assays.
Izumi S; Nozaki Y; Komori T; Takenaka O; Maeda K; Kusuhara H; Sugiyama Y
Mol Pharm; 2016 Feb; 13(2):438-48. PubMed ID: 26696140
[TBL] [Abstract][Full Text] [Related]
10. Interaction of digitalis-like compounds with liver uptake transporters NTCP, OATP1B1, and OATP1B3.
Gozalpour E; Greupink R; Wortelboer HM; Bilos A; Schreurs M; Russel FG; Koenderink JB
Mol Pharm; 2014 Jun; 11(6):1844-55. PubMed ID: 24754247
[TBL] [Abstract][Full Text] [Related]
11. Effects of uremic serum and uremic toxins on hepatic uptake of digoxin.
Tsujimoto M; Kinoshita Y; Hirata S; Otagiri M; Ohtani H; Sawada Y
Ther Drug Monit; 2008 Oct; 30(5):576-82. PubMed ID: 18708994
[TBL] [Abstract][Full Text] [Related]
12. Treatment with proteasome inhibitor bortezomib decreases organic anion transporting polypeptide (OATP) 1B3-mediated transport in a substrate-dependent manner.
Alam K; Farasyn T; Crowe A; Ding K; Yue W
PLoS One; 2017; 12(11):e0186924. PubMed ID: 29107984
[TBL] [Abstract][Full Text] [Related]
13. Pazopanib interacts with irinotecan by inhibiting UGT1A1-mediated glucuronidation, but not OATP1B1-mediated hepatic uptake, of an active metabolite SN-38.
Iwase M; Fujita KI; Nishimura Y; Seba N; Masuo Y; Ishida H; Kato Y; Kiuchi Y
Cancer Chemother Pharmacol; 2019 May; 83(5):993-998. PubMed ID: 30810774
[TBL] [Abstract][Full Text] [Related]
14. 6-Hydroxyindole is an endogenous long-lasting OATP1B1 inhibitor elevated in renal failure patients.
Masuo Y; Fujita KI; Mishiro K; Seba N; Kogi T; Okumura H; Matsumoto N; Kunishima M; Kato Y
Drug Metab Pharmacokinet; 2020 Dec; 35(6):555-562. PubMed ID: 33191090
[TBL] [Abstract][Full Text] [Related]
15. Contribution of OATP (organic anion-transporting polypeptide) family transporters to the hepatic uptake of fexofenadine in humans.
Shimizu M; Fuse K; Okudaira K; Nishigaki R; Maeda K; Kusuhara H; Sugiyama Y
Drug Metab Dispos; 2005 Oct; 33(10):1477-81. PubMed ID: 16014768
[TBL] [Abstract][Full Text] [Related]
16. Substrate-dependent effects of molecular-targeted anticancer agents on activity of organic anion transporting polypeptide 1B1.
Koide H; Tsujimoto M; Takeuchi A; Tanaka M; Ikegami Y; Tagami M; Abe S; Hashimoto M; Minegaki T; Nishiguchi K
Xenobiotica; 2018 Oct; 48(10):1059-1071. PubMed ID: 29034773
[TBL] [Abstract][Full Text] [Related]
17. Uremic serum residue decreases SN-38 sensitivity through suppression of organic anion transporter polypeptide 2B1 in LS-180 colon cancer cells.
Ozawa S; Tsujimoto M; Uchiyama H; Ito N; Morishita S; Yamamoto M; Irie R; Sakashita T; Tachiki H; Furukubo T; Izumi S; Yamakawa T; Minegaki T; Nishiguchi K
Sci Rep; 2019 Oct; 9(1):15464. PubMed ID: 31664047
[TBL] [Abstract][Full Text] [Related]
18. A furan fatty acid and indoxyl sulfate are the putative inhibitors of thyroxine hepatocyte transport in uremia.
Lim CF; Bernard BF; de Jong M; Docter R; Krenning EP; Hennemann G
J Clin Endocrinol Metab; 1993 Feb; 76(2):318-24. PubMed ID: 8432774
[TBL] [Abstract][Full Text] [Related]
19. Renal disposition of a furan dicarboxylic acid and other uremic toxins in the rat.
Tsutsumi Y; Deguchi T; Takano M; Takadate A; Lindup WE; Otagiri M
J Pharmacol Exp Ther; 2002 Nov; 303(2):880-7. PubMed ID: 12388676
[TBL] [Abstract][Full Text] [Related]
20. Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor.
Yamada A; Maeda K; Kamiyama E; Sugiyama D; Kondo T; Shiroyanagi Y; Nakazawa H; Okano T; Adachi M; Schuetz JD; Adachi Y; Hu Z; Kusuhara H; Sugiyama Y
Drug Metab Dispos; 2007 Dec; 35(12):2166-76. PubMed ID: 17823233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
